Nasdaq: ARWR

Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ARWR. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ARWR
Exchange
Nasdaq
SEC CIK
879407
Official filings
SEC EDGAR

Research ARWR

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Arrowhead Pharmaceuticals, Inc.'s stock ticker?

Arrowhead Pharmaceuticals, Inc. trades under the ticker symbol ARWR on Nasdaq. Its SEC Central Index Key (CIK) is 879407.

Where can I read Arrowhead Pharmaceuticals, Inc.'s SEC filings?

The ARWR SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Arrowhead Pharmaceuticals, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ARWR's financial statements?

The ARWR Financials page shows Arrowhead Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ARWR compare with its peers and the market?

The ARWR Peer Comparison page lines Arrowhead Pharmaceuticals, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.